Now showing items 1-8 of 8

    • Sacchettini, James, C.; Miller, Matthew W.; Wallis, Deann; Zhou, Nian E.; Fossum, Theresa W. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2019-03-12)
      Compositions and methods for inhibiting and/or sensitizing or re-sensitizing a parasite to an antiparasitic drug are provided. The compositions can comprise a rifamycin derivative or a pharmaceutically acceptable salt, ...
    • Reddy, Manchi C. M.; Sacchettini, James C.; Zhou, Nian E.; McCutchen, Billy F. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2021-08-10)
      Compositions and methods for inhibiting and/or sensitizing or re-sensitizing a parasite to an antiparasitic drug are provided. The compositions can comprise a an arylphenoxypropionate derivative, an aryloxyphenoxyacetate ...
    • Reddy, Manchi C. M.; Sacchettini, James C.; Zhou, Nian E.; McClutchen, Billy F. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2020-01-28)
      Compositions and methods for inhibiting and/or sensitizing or re-sensitizing a parasite to an antiparasitic drug are provided. The compositions can comprise a an arylphenoxypropionate derivative, an aryloxyphenoxyacetate ...
    • Sacchettini, James; Zhou, Niam; Baker, Dwight; Maxwell, Steven A.; Wallis, Deeann (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2015-09-15)
      The disclosure provides rifamycin and rifamycin derivative compositions, including rifabutin and rifabutin derivative compositions able to cause drug-sensitization in a cancer cell or inhibition of a cancer cell. The ...
    • Sacchettini, James; Zhou, Niam; Baker, Dwight; Maxwell, Steven A.; Wallis, Deeann (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2018-01-16)
      The disclosure provides rifamycin and rifamycin derivative compositions, including rifabutin and rifabutin derivative compositions able to cause drug-sensitization in a cancer cell or inhibition of a cancer cell. The ...
    • Sacchettini, James; Zhou, Niam; Baker, Dwight; Maxwell, Steven A.; Wallis, Deeann (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2017-01-10)
      The disclosure provides rifamycin and rifamycin derivative compositions, including rifabutin and rifabutin derivative compositions able to cause drug-sensitization in a cancer cell or inhibition of a cancer cell. The ...
    • Reddy, Manchi C. M.; Sacchettini, James C.; Zhou, Nian E.; Mccutchen, Billy F. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2019-05-28)
      A composition comprising a drug selected from the group consisting of an arylphenoxypropionate derivative, an aryloxyphenoxyacetate derivative, an aryloxyphenylacetate derivative, a substituted quinol, or a salt, hydrate, ...
    • Reddy, Manchi C. M.; Sacchettini, James C.; Zhou, Nian E.; McCutchen, Billy F. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2019-05-28)
      A composition comprising a drug selected from the group consisting of an arylphenoxypropionate derivative, an aryloxyphenoxyacetate derivative, an aryloxyphenylacetate derivative, a substituted quinol, or a salt, hydrate, ...